Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
About this study
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.
- Condition
- Nasopharyngeal Cancer, Prostate Cancer, Other Cancer
- Sponsor
- National Cancer Centre, Singapore
Who can join
- Age
- 21 to 99 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 5
- Minimum age: 21 years
- Maximum age: 99 years
- Study condition: Nasopharyngeal Cancer, Prostate Cancer, Other Cancer
- Patients with severe side effects from radiotherapy
- Patients with a type of cancer that is associated with sensitivity to radiotherapy
Exclusion 1
- Age of patient must be between 21 (inclusive) and 99 (exclusive)
Where
1 site, 1 recruiting
National Cancer Center Singapore
Singapore, Singapore
Contact
-
Melvin Chua, MD
-
Enya Ong
+65 6436 8000 enya.ong.h.w@nccs.com.sg
Potential match only. Final eligibility is determined by the study team.